Press release
Global Biologics Market Size projected to Reach USD 769.7 Billion by 2033 | CAGR of 7.38%.
The global biologics market was valued at USD 377.6 Billion in 2024 and is expected to reach USD 769.7 Billion by 2033, growing at a CAGR of 7.38% during the forecast period 2025-2033. The market growth is driven by rising chronic disease prevalence, technological advancements enabling targeted therapies, and advanced drug delivery systems. North America dominates with over 44.8% market share. This Biologics Market report provides comprehensive insights by
source, product, disease, manufacturing, and region.
Study Assumption Years
• Base Year: 2024
• Historical Years: 2019-2024
• Forecast Period: 2025-2033
Biologics Market Key Takeaways
• The global biologics market size was USD 377.6 Billion in 2024.
• The market is projected to grow at a CAGR of 7.38% from 2025 to 2033.
• Forecasted market size is USD 769.7 Billion by 2033.
• North America held a market share of over 44.8% in 2024.
• Increasing chronic diseases and geriatric population drive biologics demand.
• Continuous innovations in targeted therapies and advanced drug delivery systems boost growth.
• Regulatory harmonization facilitates faster market access and product approvals.
Sample Request Link: https://www.imarcgroup.com/biologics-market/requestsample
Market Growth Factors
The biologics market growth is primarily driven by the increasing incidence of chronic diseases such as diabetes, cancer, and autoimmune diseases, alongside a growing geriatric population demanding more effective therapeutics. Investments in research and development accelerate the launch of next-generation biologics and biosimilars, providing cost-effective alternatives. Regulatory approvals and governmental support further enhance availability and adoption, thereby fueling the market expansion.
Substantial innovation in targeted therapies enhances treatment specificity and efficacy while reducing side effects. From 2006 to 2020, 72 approvals for 51 drugs targeting 36 genomic indications across 18 cancer types significantly increased eligibility for genome-targeted therapies and improved response rates. Technologies like ultrasound-activated drug delivery and dual-target CAR-T therapies targeting proteins such as EGFR and IL13Rα2 exemplify advances that increase the demand for these complex molecules and personalized medicine.
Advanced drug delivery systems are crucial for improving therapy effectiveness and patient compliance. By 2024, nanotechnology is anticipated to surpass USD 125 Billion globally, boosting targeted delivery, stability, and efficacy of biologics. Innovations such as the Spatiotemporal On-Demand Patch SOP enable wireless, controlled drug delivery, replacing frequent injections with convenient dosing schedules. This patient-centric approach aligns with increased investments to maximize therapeutic efficiency and drive market growth.
Market Segmentation
Analysis by Source:
• Microbial: Accounts for 58.5% share due to cost-effectiveness, scalability, and high productivity. Used widely for producing recombinant proteins, enzymes, and vaccines with fast growth rates and simple genetic manipulation. Dominates production of insulin, growth hormones, and therapeutic enzymes.
Analysis by Product:
• Monoclonal Antibodies: Largest segment with 66.7% share, critical in treating cancer, autoimmune diseases, and infections. Target antigen specificity underpins personalized medicine. Advances like bispecific antibodies and antibody-drug conjugates enhance efficacy. Growth is supported by biosimilar adoption expanding accessibility.
Analysis by Disease:
• Oncology: Holds 28.7% market share, propelled by rising cancer prevalence and adoption of targeted therapies including monoclonal antibodies, checkpoint inhibitors, and cell-based therapies. Regulatory approvals further support market expansion in oncology.
Analysis by Manufacturing:
• In-House: Leads with 84.8% share due to production control, intellectual property protection, and regulatory adherence. Modular and continuous manufacturing technologies improve scalability and efficiency without dependency on external partners.
Regional Insights
North America dominates the biologics market with over 44.8% share in 2024, backed by robust healthcare infrastructure, heavy biopharmaceutical research investments, and favorable regulatory support such as fast-track approvals. The U.S. comprises 88.7% of this regional market, driven by high healthcare spending, broad insurance coverage, and rising chronic disease prevalence, fostering innovation and widespread adoption of biologic therapies.
Contact Out Analysts for Brochure Requests, Customization, and Inquiries Before Purchase: https://www.imarcgroup.com/request?type=report&id=3883&flag=C
Recent Developments & News
• April 2025: Samsung Biologics adopted a Quality-by-Design (QbD) framework to enhance biopharmaceutical product lifecycle management, improving scalability and compliance in CDMO operations.
• June 2025: WuXi Biologics partnered with Virogen Biotechnology to manufacture VG712, progressing to planned Biologics License Application between 2027-2028.
• May 2025: Forge Biologics entered a manufacturing partnership with Fractyl Health for Rejuva, an AAV-based pancreatic gene therapy for obesity and type 2 diabetes.
• May 2025: Biocon Biologics secured U.S. market access for YESINTEKTM (ustekinumab-kfce) covering over 100 million lives, approved for autoimmune conditions by FDA in December 2024.
• March 2024: Lonza acquired Roche's California biologic drug manufacturing site for USD 1.2 Billion, enhancing global manufacturing capacity.
• March 2024: Pearl Bio collaborated with Merck to develop biologics with non-standard amino acids, focusing on synthetic biology and pharmaceutical innovation.
• March 2024: Eris Lifesciences acquired Biocon Biologics' branded formulation business securing a 10-year supply agreement in India's growing market.
Key Players
• AbbVie Inc.
• Amgen Inc.
• AstraZeneca plc
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline plc
• Johnson & Johnson
• Merck KGaA
• Novartis AG
• Pfizer Inc.
• Sanofi
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
👉Get Custom Market Research for Your Business:- https://www.imarcgroup.com/request?type=report&id=3883&flag=E
Contact Us
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-201971-6302
About Us
IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Biologics Market Size projected to Reach USD 769.7 Billion by 2033 | CAGR of 7.38%. here
News-ID: 4393577 • Views: …
More Releases from IMARC Group
Global Healthcare Extended Reality Market Size projected to Reach USD USD 67.7 B …
Market Overview
The global healthcare extended reality market reached a size of USD 7.8 Billion in 2024. It is projected to grow at a compound annual growth rate (CAGR) of 26.98% from 2025 to 2033, reaching USD 67.7 Billion by the end of the forecast period. Growth is driven by increasing remote medical consultations, telehealth advancements, and integration of artificial intelligence and data analytics within the healthcare extended reality ecosystem. These…
Global Ferroalloys Market Size projected to Reach USD 97.4 Billion by 2033 | CAG …
Market Overview
The global Ferroalloys Market reached a size of USD 56.7 Billion in 2024. It is projected to grow to USD 97.4 Billion by 2033 at a CAGR of 5.89% during the forecast period 2025-2033. Growth is driven by the expanding steel industry, rising demand for high-strength, low-alloy steels in diverse sectors, and advancements in production technologies.
Study Assumption Years
• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033
Ferroalloys Market Key Takeaways
• Current Market Size:…
Dog food Segment Secures 42.09% Europe Pet Food Market Share in 2025 Driven by D …
Market Overview
The Europe pet food market size was valued at USD 37.77 Billion in 2025 and is expected to reach USD 63.29 Billion by 2034, growing at a compound annual growth rate (CAGR) of 5.90% from 2026 to 2034. The market growth is driven by accelerating pet humanization, demographic shifts towards single-person households, and demand for functional nutrition products. Premium formulations enriched with probiotics and omega fatty acids are increasingly…
Electric Wire Manufacturing Plant DPR - 2026, Market Trends, Setup Requirements, …
The global electrification drive, expanding power infrastructure, and accelerating industrial modernization have positioned electric wire as a foundational component of modern economies. Electrical wire functions as a conductive material enabling safe and efficient transmission of electrical current between different components and systems, manufactured from high-purity copper or aluminum with or without insulation depending on specific application requirements. The material exhibits high electrical conductivity, thermal stability, and mechanical strength, making it…
More Releases for Bio
Human Plasma Products Market 2023: Industry Future Trends | Takeda, CSL, Grifols …
The Human Plasma Products market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with…
Gene Therapy Products Market | Advantagene, Avalanche Bio, Bluebird Bio, Cellado …
The global gene therapy products market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the gene therapy products market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Bio-based Polymethyl Methacrylate (Bio-PMMA) Market 2023 | Detailed Report
The Bio-based Polymethyl Methacrylate (Bio-PMMA) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The Bio-based Polymethyl Methacrylate (Bio-PMMA) research report…
Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary…
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the…
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the…
